nodes	percent_of_prediction	percent_of_DWPC	metapath
Simvastatin—CYP3A4—bone cancer	0.332	1	CbGaD
Simvastatin—UGT2B7—Epirubicin—bone cancer	0.12	0.242	CbGbCtD
Simvastatin—ABCC2—Carboplatin—bone cancer	0.0586	0.118	CbGbCtD
Simvastatin—ABCC2—Cisplatin—bone cancer	0.0501	0.101	CbGbCtD
Simvastatin—SLCO1A2—Methotrexate—bone cancer	0.0392	0.0791	CbGbCtD
Simvastatin—SLCO1B1—Methotrexate—bone cancer	0.037	0.0746	CbGbCtD
Simvastatin—ABCC2—Doxorubicin—bone cancer	0.0336	0.0677	CbGbCtD
Simvastatin—ABCC2—Methotrexate—bone cancer	0.0325	0.0656	CbGbCtD
Simvastatin—CYP2B6—Cisplatin—bone cancer	0.0318	0.0642	CbGbCtD
Simvastatin—CYP2B6—Doxorubicin—bone cancer	0.0213	0.043	CbGbCtD
Simvastatin—CYP2C9—Cisplatin—bone cancer	0.0168	0.0339	CbGbCtD
Simvastatin—ABCB1—Cisplatin—bone cancer	0.0163	0.0329	CbGbCtD
Simvastatin—ABCB1—Doxorubicin—bone cancer	0.0109	0.0221	CbGbCtD
Simvastatin—ABCB1—Methotrexate—bone cancer	0.0106	0.0214	CbGbCtD
Simvastatin—CYP2D6—Doxorubicin—bone cancer	0.0103	0.0208	CbGbCtD
Simvastatin—CYP3A4—Doxorubicin—bone cancer	0.00656	0.0132	CbGbCtD
Simvastatin—Lovastatin—CYP3A4—bone cancer	0.0014	0.5	CrCbGaD
Simvastatin—Pravastatin—CYP3A4—bone cancer	0.0014	0.5	CrCbGaD
Simvastatin—Pancreatitis—Cisplatin—bone cancer	0.000436	0.007	CcSEcCtD
Simvastatin—Abdominal discomfort—Cisplatin—bone cancer	0.000426	0.00685	CcSEcCtD
Simvastatin—Jaundice cholestatic—Epirubicin—bone cancer	0.000414	0.00666	CcSEcCtD
Simvastatin—Inflammation—Methotrexate—bone cancer	0.000401	0.00644	CcSEcCtD
Simvastatin—Vasculitis—Methotrexate—bone cancer	0.000398	0.0064	CcSEcCtD
Simvastatin—Neuropathy peripheral—Cisplatin—bone cancer	0.000389	0.00624	CcSEcCtD
Simvastatin—Jaundice cholestatic—Doxorubicin—bone cancer	0.000383	0.00616	CcSEcCtD
Simvastatin—Inflammation—Epirubicin—bone cancer	0.000375	0.00603	CcSEcCtD
Simvastatin—Hepatocellular injury—Epirubicin—bone cancer	0.000364	0.00585	CcSEcCtD
Simvastatin—Phosphatase alkaline increased—Epirubicin—bone cancer	0.000364	0.00585	CcSEcCtD
Simvastatin—Gynaecomastia—Methotrexate—bone cancer	0.000348	0.00559	CcSEcCtD
Simvastatin—Inflammation—Doxorubicin—bone cancer	0.000347	0.00558	CcSEcCtD
Simvastatin—Phosphatase alkaline increased—Doxorubicin—bone cancer	0.000337	0.00541	CcSEcCtD
Simvastatin—Hepatocellular injury—Doxorubicin—bone cancer	0.000337	0.00541	CcSEcCtD
Simvastatin—Flushing—Cisplatin—bone cancer	0.00033	0.00531	CcSEcCtD
Simvastatin—Diabetes mellitus—Methotrexate—bone cancer	0.000325	0.00522	CcSEcCtD
Simvastatin—Photosensitivity—Methotrexate—bone cancer	0.000322	0.00517	CcSEcCtD
Simvastatin—Alopecia—Cisplatin—bone cancer	0.000315	0.00505	CcSEcCtD
Simvastatin—Hepatic failure—Methotrexate—bone cancer	0.000314	0.00505	CcSEcCtD
Simvastatin—Erythema—Cisplatin—bone cancer	0.00031	0.00498	CcSEcCtD
Simvastatin—Flatulence—Cisplatin—bone cancer	0.000305	0.00491	CcSEcCtD
Simvastatin—Blood alkaline phosphatase increased—Epirubicin—bone cancer	0.000304	0.00488	CcSEcCtD
Simvastatin—Diabetes mellitus—Epirubicin—bone cancer	0.000304	0.00488	CcSEcCtD
Simvastatin—Hepatic function abnormal—Epirubicin—bone cancer	0.000302	0.00486	CcSEcCtD
Simvastatin—Photosensitivity—Epirubicin—bone cancer	0.000301	0.00483	CcSEcCtD
Simvastatin—Muscle spasms—Cisplatin—bone cancer	0.000298	0.00479	CcSEcCtD
Simvastatin—Vascular purpura—Epirubicin—bone cancer	0.000295	0.00475	CcSEcCtD
Simvastatin—Eczema—Epirubicin—bone cancer	0.000294	0.00472	CcSEcCtD
Simvastatin—Hepatic failure—Epirubicin—bone cancer	0.000294	0.00472	CcSEcCtD
Simvastatin—Vision blurred—Cisplatin—bone cancer	0.000292	0.00469	CcSEcCtD
Simvastatin—Tremor—Cisplatin—bone cancer	0.00029	0.00466	CcSEcCtD
Simvastatin—Ill-defined disorder—Cisplatin—bone cancer	0.000287	0.00462	CcSEcCtD
Simvastatin—Anaemia—Cisplatin—bone cancer	0.000286	0.0046	CcSEcCtD
Simvastatin—Blood alkaline phosphatase increased—Doxorubicin—bone cancer	0.000281	0.00452	CcSEcCtD
Simvastatin—Diabetes mellitus—Doxorubicin—bone cancer	0.000281	0.00452	CcSEcCtD
Simvastatin—Hepatic function abnormal—Doxorubicin—bone cancer	0.00028	0.00449	CcSEcCtD
Simvastatin—Malaise—Cisplatin—bone cancer	0.000279	0.00449	CcSEcCtD
Simvastatin—Photosensitivity—Doxorubicin—bone cancer	0.000278	0.00447	CcSEcCtD
Simvastatin—Leukopenia—Cisplatin—bone cancer	0.000277	0.00446	CcSEcCtD
Simvastatin—Purpura—Epirubicin—bone cancer	0.000274	0.0044	CcSEcCtD
Simvastatin—Vascular purpura—Doxorubicin—bone cancer	0.000273	0.00439	CcSEcCtD
Simvastatin—Eczema—Doxorubicin—bone cancer	0.000272	0.00437	CcSEcCtD
Simvastatin—Hepatic failure—Doxorubicin—bone cancer	0.000272	0.00437	CcSEcCtD
Simvastatin—Myalgia—Cisplatin—bone cancer	0.000264	0.00424	CcSEcCtD
Simvastatin—Anxiety—Cisplatin—bone cancer	0.000263	0.00422	CcSEcCtD
Simvastatin—Discomfort—Cisplatin—bone cancer	0.000261	0.00419	CcSEcCtD
Simvastatin—Toxic epidermal necrolysis—Methotrexate—bone cancer	0.000254	0.00408	CcSEcCtD
Simvastatin—Purpura—Doxorubicin—bone cancer	0.000254	0.00408	CcSEcCtD
Simvastatin—Oedema—Cisplatin—bone cancer	0.000253	0.00406	CcSEcCtD
Simvastatin—Anaphylactic shock—Cisplatin—bone cancer	0.000253	0.00406	CcSEcCtD
Simvastatin—Infection—Cisplatin—bone cancer	0.000251	0.00404	CcSEcCtD
Simvastatin—Thrombocytopenia—Cisplatin—bone cancer	0.000248	0.00398	CcSEcCtD
Simvastatin—Eosinophilia—Methotrexate—bone cancer	0.000242	0.00388	CcSEcCtD
Simvastatin—Anorexia—Cisplatin—bone cancer	0.000241	0.00387	CcSEcCtD
Simvastatin—Pancreatitis—Methotrexate—bone cancer	0.000239	0.00384	CcSEcCtD
Simvastatin—Toxic epidermal necrolysis—Epirubicin—bone cancer	0.000238	0.00382	CcSEcCtD
Simvastatin—Abdominal discomfort—Methotrexate—bone cancer	0.000234	0.00376	CcSEcCtD
Simvastatin—Gastritis—Epirubicin—bone cancer	0.000234	0.00376	CcSEcCtD
Simvastatin—Muscular weakness—Epirubicin—bone cancer	0.000233	0.00374	CcSEcCtD
Simvastatin—Musculoskeletal discomfort—Cisplatin—bone cancer	0.00023	0.0037	CcSEcCtD
Simvastatin—Paraesthesia—Cisplatin—bone cancer	0.000227	0.00365	CcSEcCtD
Simvastatin—Upper respiratory tract infection—Methotrexate—bone cancer	0.000227	0.00364	CcSEcCtD
Simvastatin—Eosinophilia—Epirubicin—bone cancer	0.000226	0.00363	CcSEcCtD
Simvastatin—Dyspnoea—Cisplatin—bone cancer	0.000225	0.00362	CcSEcCtD
Simvastatin—Erectile dysfunction—Methotrexate—bone cancer	0.000225	0.00361	CcSEcCtD
Simvastatin—Pancreatitis—Epirubicin—bone cancer	0.000224	0.0036	CcSEcCtD
Simvastatin—Photosensitivity reaction—Methotrexate—bone cancer	0.000223	0.00358	CcSEcCtD
Simvastatin—Toxic epidermal necrolysis—Doxorubicin—bone cancer	0.00022	0.00354	CcSEcCtD
Simvastatin—Decreased appetite—Cisplatin—bone cancer	0.00022	0.00353	CcSEcCtD
Simvastatin—Bronchitis—Epirubicin—bone cancer	0.00022	0.00353	CcSEcCtD
Simvastatin—Gastrointestinal disorder—Cisplatin—bone cancer	0.000218	0.00351	CcSEcCtD
Simvastatin—Depression—Methotrexate—bone cancer	0.000217	0.00349	CcSEcCtD
Simvastatin—UGT1A3—Biological oxidations—CYP3A4—bone cancer	0.000217	0.00202	CbGpPWpGaD
Simvastatin—Gastritis—Doxorubicin—bone cancer	0.000216	0.00348	CcSEcCtD
Simvastatin—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000216	0.00201	CbGpPWpGaD
Simvastatin—Pain—Cisplatin—bone cancer	0.000216	0.00347	CcSEcCtD
Simvastatin—Stevens-Johnson syndrome—Methotrexate—bone cancer	0.000216	0.00347	CcSEcCtD
Simvastatin—Muscular weakness—Doxorubicin—bone cancer	0.000216	0.00346	CcSEcCtD
Simvastatin—ITGB2—Focal Adhesion—JUN—bone cancer	0.000214	0.002	CbGpPWpGaD
Simvastatin—UGT1A3—Metapathway biotransformation—CYP3A4—bone cancer	0.000214	0.00199	CbGpPWpGaD
Simvastatin—CYP2B6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000213	0.00199	CbGpPWpGaD
Simvastatin—ITGB2—Extracellular matrix organization—MMP2—bone cancer	0.000213	0.00199	CbGpPWpGaD
Simvastatin—Upper respiratory tract infection—Epirubicin—bone cancer	0.000212	0.00341	CcSEcCtD
Simvastatin—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000211	0.00197	CbGpPWpGaD
Simvastatin—UGT1A3—NRF2 pathway—GSTP1—bone cancer	0.000211	0.00197	CbGpPWpGaD
Simvastatin—UGT1A3—NRF2 pathway—TGFBR2—bone cancer	0.000211	0.00197	CbGpPWpGaD
Simvastatin—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	0.000211	0.00197	CbGpPWpGaD
Simvastatin—Eosinophilia—Doxorubicin—bone cancer	0.000209	0.00336	CcSEcCtD
Simvastatin—CYP3A5—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000209	0.00194	CbGpPWpGaD
Simvastatin—Photosensitivity reaction—Epirubicin—bone cancer	0.000208	0.00335	CcSEcCtD
Simvastatin—Feeling abnormal—Cisplatin—bone cancer	0.000208	0.00335	CcSEcCtD
Simvastatin—Pancreatitis—Doxorubicin—bone cancer	0.000207	0.00333	CcSEcCtD
Simvastatin—Bronchitis—Doxorubicin—bone cancer	0.000203	0.00326	CcSEcCtD
Simvastatin—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.000202	0.00324	CcSEcCtD
Simvastatin—Body temperature increased—Cisplatin—bone cancer	0.0002	0.00321	CcSEcCtD
Simvastatin—Neuropathy peripheral—Epirubicin—bone cancer	0.0002	0.00321	CcSEcCtD
Simvastatin—Jaundice—Epirubicin—bone cancer	0.000198	0.00319	CcSEcCtD
Simvastatin—Upper respiratory tract infection—Doxorubicin—bone cancer	0.000196	0.00316	CcSEcCtD
Simvastatin—UGT1A3—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	0.000196	0.00182	CbGpPWpGaD
Simvastatin—Hepatitis—Methotrexate—bone cancer	0.000195	0.00314	CcSEcCtD
Simvastatin—Photosensitivity reaction—Doxorubicin—bone cancer	0.000193	0.0031	CcSEcCtD
Simvastatin—Sinusitis—Epirubicin—bone cancer	0.000191	0.00307	CcSEcCtD
Simvastatin—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.000187	0.003	CcSEcCtD
Simvastatin—Hypersensitivity—Cisplatin—bone cancer	0.000186	0.00299	CcSEcCtD
Simvastatin—UGT1A3—Biological oxidations—GSTP1—bone cancer	0.000185	0.00173	CbGpPWpGaD
Simvastatin—Erythema multiforme—Methotrexate—bone cancer	0.000185	0.00297	CcSEcCtD
Simvastatin—Neuropathy peripheral—Doxorubicin—bone cancer	0.000185	0.00297	CcSEcCtD
Simvastatin—UGT2B7—Biological oxidations—CYP3A4—bone cancer	0.000184	0.00172	CbGpPWpGaD
Simvastatin—Jaundice—Doxorubicin—bone cancer	0.000184	0.00295	CcSEcCtD
Simvastatin—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000183	0.0017	CbGpPWpGaD
Simvastatin—HMGCR—Integrated Breast Cancer Pathway—CDK4—bone cancer	0.000183	0.0017	CbGpPWpGaD
Simvastatin—UGT1A3—Metapathway biotransformation—GSTP1—bone cancer	0.000183	0.0017	CbGpPWpGaD
Simvastatin—Hepatitis—Epirubicin—bone cancer	0.000183	0.00294	CcSEcCtD
Simvastatin—UGT2B7—Metapathway biotransformation—CYP3A4—bone cancer	0.000182	0.00169	CbGpPWpGaD
Simvastatin—Asthenia—Cisplatin—bone cancer	0.000181	0.00291	CcSEcCtD
Simvastatin—CYP2C8—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000181	0.00168	CbGpPWpGaD
Simvastatin—UGT2B7—NRF2 pathway—GSTP1—bone cancer	0.00018	0.00167	CbGpPWpGaD
Simvastatin—UGT2B7—NRF2 pathway—TGFBR2—bone cancer	0.00018	0.00167	CbGpPWpGaD
Simvastatin—Sinusitis—Doxorubicin—bone cancer	0.000177	0.00284	CcSEcCtD
Simvastatin—CYP2B6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000175	0.00163	CbGpPWpGaD
Simvastatin—Chills—Methotrexate—bone cancer	0.000175	0.00282	CcSEcCtD
Simvastatin—Diarrhoea—Cisplatin—bone cancer	0.000173	0.00278	CcSEcCtD
Simvastatin—Erythema multiforme—Epirubicin—bone cancer	0.000173	0.00278	CcSEcCtD
Simvastatin—Alopecia—Methotrexate—bone cancer	0.000173	0.00277	CcSEcCtD
Simvastatin—UGT1A1—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	0.000172	0.0016	CbGpPWpGaD
Simvastatin—CYP3A5—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000171	0.0016	CbGpPWpGaD
Simvastatin—Mental disorder—Methotrexate—bone cancer	0.000171	0.00275	CcSEcCtD
Simvastatin—Erythema—Methotrexate—bone cancer	0.00017	0.00273	CcSEcCtD
Simvastatin—Flushing—Epirubicin—bone cancer	0.00017	0.00273	CcSEcCtD
Simvastatin—Hepatitis—Doxorubicin—bone cancer	0.000169	0.00272	CcSEcCtD
Simvastatin—ITGB2—Focal Adhesion—EGFR—bone cancer	0.000169	0.00157	CbGpPWpGaD
Simvastatin—Dysgeusia—Methotrexate—bone cancer	0.000166	0.00268	CcSEcCtD
Simvastatin—Chills—Epirubicin—bone cancer	0.000164	0.00263	CcSEcCtD
Simvastatin—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000163	0.00152	CbGpPWpGaD
Simvastatin—HMGCR—Integrated Breast Cancer Pathway—BRAF—bone cancer	0.000162	0.00151	CbGpPWpGaD
Simvastatin—Alopecia—Epirubicin—bone cancer	0.000162	0.0026	CcSEcCtD
Simvastatin—CYP2C19—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000161	0.0015	CbGpPWpGaD
Simvastatin—Vomiting—Cisplatin—bone cancer	0.000161	0.00258	CcSEcCtD
Simvastatin—ITGB2—Hemostasis—PLAU—bone cancer	0.000161	0.0015	CbGpPWpGaD
Simvastatin—ITGB2—Extracellular matrix organization—MMP9—bone cancer	0.00016	0.00149	CbGpPWpGaD
Simvastatin—Vision blurred—Methotrexate—bone cancer	0.00016	0.00257	CcSEcCtD
Simvastatin—Mental disorder—Epirubicin—bone cancer	0.00016	0.00257	CcSEcCtD
Simvastatin—Erythema multiforme—Doxorubicin—bone cancer	0.00016	0.00257	CcSEcCtD
Simvastatin—Rash—Cisplatin—bone cancer	0.000159	0.00256	CcSEcCtD
Simvastatin—HMGCR—Metabolism—NDUFA12—bone cancer	0.000159	0.00148	CbGpPWpGaD
Simvastatin—Dermatitis—Cisplatin—bone cancer	0.000159	0.00256	CcSEcCtD
Simvastatin—Erythema—Epirubicin—bone cancer	0.000159	0.00256	CcSEcCtD
Simvastatin—HMGCR—Integrated Breast Cancer Pathway—RB1—bone cancer	0.000159	0.00148	CbGpPWpGaD
Simvastatin—Ill-defined disorder—Methotrexate—bone cancer	0.000158	0.00253	CcSEcCtD
Simvastatin—UGT2B7—Biological oxidations—GSTP1—bone cancer	0.000158	0.00147	CbGpPWpGaD
Simvastatin—Anaemia—Methotrexate—bone cancer	0.000157	0.00252	CcSEcCtD
Simvastatin—Flushing—Doxorubicin—bone cancer	0.000157	0.00252	CcSEcCtD
Simvastatin—Flatulence—Epirubicin—bone cancer	0.000157	0.00252	CcSEcCtD
Simvastatin—Dysgeusia—Epirubicin—bone cancer	0.000156	0.0025	CcSEcCtD
Simvastatin—UGT2B7—Metapathway biotransformation—GSTP1—bone cancer	0.000155	0.00145	CbGpPWpGaD
Simvastatin—Malaise—Methotrexate—bone cancer	0.000153	0.00246	CcSEcCtD
Simvastatin—Muscle spasms—Epirubicin—bone cancer	0.000153	0.00246	CcSEcCtD
Simvastatin—Vertigo—Methotrexate—bone cancer	0.000153	0.00245	CcSEcCtD
Simvastatin—Leukopenia—Methotrexate—bone cancer	0.000152	0.00245	CcSEcCtD
Simvastatin—Chills—Doxorubicin—bone cancer	0.000152	0.00244	CcSEcCtD
Simvastatin—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.00015	0.0014	CbGpPWpGaD
Simvastatin—Nausea—Cisplatin—bone cancer	0.00015	0.00241	CcSEcCtD
Simvastatin—Vision blurred—Epirubicin—bone cancer	0.00015	0.00241	CcSEcCtD
Simvastatin—UGT1A1—Biological oxidations—CYP3A4—bone cancer	0.00015	0.00139	CbGpPWpGaD
Simvastatin—Alopecia—Doxorubicin—bone cancer	0.000149	0.0024	CcSEcCtD
Simvastatin—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000149	0.00139	CbGpPWpGaD
Simvastatin—CYP2C8—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000148	0.00138	CbGpPWpGaD
Simvastatin—CYP2D6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000148	0.00138	CbGpPWpGaD
Simvastatin—Mental disorder—Doxorubicin—bone cancer	0.000148	0.00238	CcSEcCtD
Simvastatin—UGT1A1—Metapathway biotransformation—CYP3A4—bone cancer	0.000148	0.00138	CbGpPWpGaD
Simvastatin—Ill-defined disorder—Epirubicin—bone cancer	0.000148	0.00237	CcSEcCtD
Simvastatin—Erythema—Doxorubicin—bone cancer	0.000147	0.00237	CcSEcCtD
Simvastatin—CYP2C9—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000147	0.00137	CbGpPWpGaD
Simvastatin—Anaemia—Epirubicin—bone cancer	0.000147	0.00236	CcSEcCtD
Simvastatin—UGT1A1—NRF2 pathway—GSTP1—bone cancer	0.000146	0.00136	CbGpPWpGaD
Simvastatin—UGT1A1—NRF2 pathway—TGFBR2—bone cancer	0.000146	0.00136	CbGpPWpGaD
Simvastatin—HMGCR—AMPK Signaling—TP53—bone cancer	0.000146	0.00136	CbGpPWpGaD
Simvastatin—Flatulence—Doxorubicin—bone cancer	0.000145	0.00233	CcSEcCtD
Simvastatin—Myalgia—Methotrexate—bone cancer	0.000145	0.00233	CcSEcCtD
Simvastatin—Chest pain—Methotrexate—bone cancer	0.000145	0.00233	CcSEcCtD
Simvastatin—Arthralgia—Methotrexate—bone cancer	0.000145	0.00233	CcSEcCtD
Simvastatin—Dysgeusia—Doxorubicin—bone cancer	0.000144	0.00232	CcSEcCtD
Simvastatin—Malaise—Epirubicin—bone cancer	0.000143	0.00231	CcSEcCtD
Simvastatin—Discomfort—Methotrexate—bone cancer	0.000143	0.0023	CcSEcCtD
Simvastatin—Vertigo—Epirubicin—bone cancer	0.000143	0.0023	CcSEcCtD
Simvastatin—ABCC2—NRF2 pathway—GSTP1—bone cancer	0.000142	0.00133	CbGpPWpGaD
Simvastatin—ABCC2—NRF2 pathway—TGFBR2—bone cancer	0.000142	0.00133	CbGpPWpGaD
Simvastatin—Leukopenia—Epirubicin—bone cancer	0.000142	0.00229	CcSEcCtD
Simvastatin—Muscle spasms—Doxorubicin—bone cancer	0.000142	0.00227	CcSEcCtD
Simvastatin—Confusional state—Methotrexate—bone cancer	0.00014	0.00225	CcSEcCtD
Simvastatin—Anaphylactic shock—Methotrexate—bone cancer	0.000139	0.00223	CcSEcCtD
Simvastatin—Vision blurred—Doxorubicin—bone cancer	0.000139	0.00223	CcSEcCtD
Simvastatin—Infection—Methotrexate—bone cancer	0.000138	0.00221	CcSEcCtD
Simvastatin—Ill-defined disorder—Doxorubicin—bone cancer	0.000137	0.00219	CcSEcCtD
Simvastatin—Anaemia—Doxorubicin—bone cancer	0.000136	0.00219	CcSEcCtD
Simvastatin—Thrombocytopenia—Methotrexate—bone cancer	0.000136	0.00218	CcSEcCtD
Simvastatin—HMGCR—Integrated Breast Cancer Pathway—MDM2—bone cancer	0.000136	0.00126	CbGpPWpGaD
Simvastatin—Arthralgia—Epirubicin—bone cancer	0.000135	0.00218	CcSEcCtD
Simvastatin—Myalgia—Epirubicin—bone cancer	0.000135	0.00218	CcSEcCtD
Simvastatin—Chest pain—Epirubicin—bone cancer	0.000135	0.00218	CcSEcCtD
Simvastatin—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	0.000135	0.00126	CbGpPWpGaD
Simvastatin—Anxiety—Epirubicin—bone cancer	0.000135	0.00217	CcSEcCtD
Simvastatin—Discomfort—Epirubicin—bone cancer	0.000134	0.00215	CcSEcCtD
Simvastatin—Malaise—Doxorubicin—bone cancer	0.000133	0.00213	CcSEcCtD
Simvastatin—CYP2C19—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000133	0.00123	CbGpPWpGaD
Simvastatin—Vertigo—Doxorubicin—bone cancer	0.000132	0.00213	CcSEcCtD
Simvastatin—Anorexia—Methotrexate—bone cancer	0.000132	0.00213	CcSEcCtD
Simvastatin—HMGCR—Metabolism—NT5C3A—bone cancer	0.000132	0.00123	CbGpPWpGaD
Simvastatin—Leukopenia—Doxorubicin—bone cancer	0.000132	0.00212	CcSEcCtD
Simvastatin—ITGB2—Immune System—ATF1—bone cancer	0.000132	0.00123	CbGpPWpGaD
Simvastatin—Confusional state—Epirubicin—bone cancer	0.000131	0.0021	CcSEcCtD
Simvastatin—UGT1A3—Metabolism—NDUFA12—bone cancer	0.00013	0.00121	CbGpPWpGaD
Simvastatin—Oedema—Epirubicin—bone cancer	0.00013	0.00209	CcSEcCtD
Simvastatin—Anaphylactic shock—Epirubicin—bone cancer	0.00013	0.00209	CcSEcCtD
Simvastatin—Infection—Epirubicin—bone cancer	0.000129	0.00207	CcSEcCtD
Simvastatin—ITGB2—Innate Immune System—KIT—bone cancer	0.000129	0.0012	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—IL3—bone cancer	0.000129	0.0012	CbGpPWpGaD
Simvastatin—UGT1A1—Biological oxidations—GSTP1—bone cancer	0.000128	0.00119	CbGpPWpGaD
Simvastatin—Thrombocytopenia—Epirubicin—bone cancer	0.000127	0.00204	CcSEcCtD
Simvastatin—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000126	0.00203	CcSEcCtD
Simvastatin—UGT1A1—Metapathway biotransformation—GSTP1—bone cancer	0.000126	0.00118	CbGpPWpGaD
Simvastatin—CYP3A7—Biological oxidations—CYP3A4—bone cancer	0.000126	0.00117	CbGpPWpGaD
Simvastatin—Insomnia—Methotrexate—bone cancer	0.000126	0.00202	CcSEcCtD
Simvastatin—Myalgia—Doxorubicin—bone cancer	0.000125	0.00201	CcSEcCtD
Simvastatin—Arthralgia—Doxorubicin—bone cancer	0.000125	0.00201	CcSEcCtD
Simvastatin—Chest pain—Doxorubicin—bone cancer	0.000125	0.00201	CcSEcCtD
Simvastatin—Anxiety—Doxorubicin—bone cancer	0.000125	0.00201	CcSEcCtD
Simvastatin—Paraesthesia—Methotrexate—bone cancer	0.000125	0.002	CcSEcCtD
Simvastatin—CYP3A7—Metapathway biotransformation—CYP3A4—bone cancer	0.000124	0.00116	CbGpPWpGaD
Simvastatin—Discomfort—Doxorubicin—bone cancer	0.000124	0.00199	CcSEcCtD
Simvastatin—Anorexia—Epirubicin—bone cancer	0.000124	0.00199	CcSEcCtD
Simvastatin—Dyspnoea—Methotrexate—bone cancer	0.000124	0.00199	CcSEcCtD
Simvastatin—ITGB2—Adaptive Immune System—KIT—bone cancer	0.000124	0.00115	CbGpPWpGaD
Simvastatin—SLCO1A2—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000123	0.00115	CbGpPWpGaD
Simvastatin—Dyspepsia—Methotrexate—bone cancer	0.000122	0.00196	CcSEcCtD
Simvastatin—CYP2D6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000122	0.00113	CbGpPWpGaD
Simvastatin—Confusional state—Doxorubicin—bone cancer	0.000121	0.00195	CcSEcCtD
Simvastatin—CYP2C9—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000121	0.00112	CbGpPWpGaD
Simvastatin—Decreased appetite—Methotrexate—bone cancer	0.000121	0.00194	CcSEcCtD
Simvastatin—Anaphylactic shock—Doxorubicin—bone cancer	0.00012	0.00193	CcSEcCtD
Simvastatin—Oedema—Doxorubicin—bone cancer	0.00012	0.00193	CcSEcCtD
Simvastatin—Gastrointestinal disorder—Methotrexate—bone cancer	0.00012	0.00192	CcSEcCtD
Simvastatin—Fatigue—Methotrexate—bone cancer	0.00012	0.00192	CcSEcCtD
Simvastatin—Infection—Doxorubicin—bone cancer	0.000119	0.00192	CcSEcCtD
Simvastatin—Pain—Methotrexate—bone cancer	0.000119	0.00191	CcSEcCtD
Simvastatin—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000118	0.0019	CcSEcCtD
Simvastatin—HMGCR—Integrated Breast Cancer Pathway—JUN—bone cancer	0.000118	0.0011	CbGpPWpGaD
Simvastatin—Thrombocytopenia—Doxorubicin—bone cancer	0.000118	0.00189	CcSEcCtD
Simvastatin—Insomnia—Epirubicin—bone cancer	0.000117	0.00189	CcSEcCtD
Simvastatin—Paraesthesia—Epirubicin—bone cancer	0.000117	0.00187	CcSEcCtD
Simvastatin—Dyspnoea—Epirubicin—bone cancer	0.000116	0.00186	CcSEcCtD
Simvastatin—Anorexia—Doxorubicin—bone cancer	0.000115	0.00184	CcSEcCtD
Simvastatin—Feeling abnormal—Methotrexate—bone cancer	0.000114	0.00184	CcSEcCtD
Simvastatin—Dyspepsia—Epirubicin—bone cancer	0.000114	0.00184	CcSEcCtD
Simvastatin—Gastrointestinal pain—Methotrexate—bone cancer	0.000113	0.00182	CcSEcCtD
Simvastatin—Decreased appetite—Epirubicin—bone cancer	0.000113	0.00181	CcSEcCtD
Simvastatin—Gastrointestinal disorder—Epirubicin—bone cancer	0.000112	0.0018	CcSEcCtD
Simvastatin—ABCC2—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000112	0.00104	CbGpPWpGaD
Simvastatin—Fatigue—Epirubicin—bone cancer	0.000112	0.0018	CcSEcCtD
Simvastatin—Constipation—Epirubicin—bone cancer	0.000111	0.00178	CcSEcCtD
Simvastatin—Pain—Epirubicin—bone cancer	0.000111	0.00178	CcSEcCtD
Simvastatin—UGT2B7—Metabolism—NDUFA12—bone cancer	0.00011	0.00103	CbGpPWpGaD
Simvastatin—Urticaria—Methotrexate—bone cancer	0.00011	0.00177	CcSEcCtD
Simvastatin—Abdominal pain—Methotrexate—bone cancer	0.00011	0.00176	CcSEcCtD
Simvastatin—Body temperature increased—Methotrexate—bone cancer	0.00011	0.00176	CcSEcCtD
Simvastatin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	0.000109	0.00102	CbGpPWpGaD
Simvastatin—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000109	0.00176	CcSEcCtD
Simvastatin—Insomnia—Doxorubicin—bone cancer	0.000109	0.00175	CcSEcCtD
Simvastatin—Paraesthesia—Doxorubicin—bone cancer	0.000108	0.00173	CcSEcCtD
Simvastatin—CYP3A7—Biological oxidations—GSTP1—bone cancer	0.000108	0.001	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—NT5C3A—bone cancer	0.000108	0.001	CbGpPWpGaD
Simvastatin—Dyspnoea—Doxorubicin—bone cancer	0.000107	0.00172	CcSEcCtD
Simvastatin—Feeling abnormal—Epirubicin—bone cancer	0.000107	0.00172	CcSEcCtD
Simvastatin—CYP3A7—Metapathway biotransformation—GSTP1—bone cancer	0.000106	0.000989	CbGpPWpGaD
Simvastatin—SLCO1A2—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000106	0.000989	CbGpPWpGaD
Simvastatin—Gastrointestinal pain—Epirubicin—bone cancer	0.000106	0.00171	CcSEcCtD
Simvastatin—Dyspepsia—Doxorubicin—bone cancer	0.000106	0.0017	CcSEcCtD
Simvastatin—SLCO1B1—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000105	0.00098	CbGpPWpGaD
Simvastatin—Decreased appetite—Doxorubicin—bone cancer	0.000104	0.00168	CcSEcCtD
Simvastatin—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000104	0.00167	CcSEcCtD
Simvastatin—Fatigue—Doxorubicin—bone cancer	0.000104	0.00166	CcSEcCtD
Simvastatin—Urticaria—Epirubicin—bone cancer	0.000103	0.00166	CcSEcCtD
Simvastatin—Pain—Doxorubicin—bone cancer	0.000103	0.00165	CcSEcCtD
Simvastatin—Constipation—Doxorubicin—bone cancer	0.000103	0.00165	CcSEcCtD
Simvastatin—Abdominal pain—Epirubicin—bone cancer	0.000103	0.00165	CcSEcCtD
Simvastatin—Body temperature increased—Epirubicin—bone cancer	0.000103	0.00165	CcSEcCtD
Simvastatin—Hypersensitivity—Methotrexate—bone cancer	0.000102	0.00164	CcSEcCtD
Simvastatin—ITGB2—Innate Immune System—MDM2—bone cancer	0.000101	0.000944	CbGpPWpGaD
Simvastatin—Asthenia—Methotrexate—bone cancer	9.96e-05	0.0016	CcSEcCtD
Simvastatin—Feeling abnormal—Doxorubicin—bone cancer	9.9e-05	0.00159	CcSEcCtD
Simvastatin—Gastrointestinal pain—Doxorubicin—bone cancer	9.83e-05	0.00158	CcSEcCtD
Simvastatin—Pruritus—Methotrexate—bone cancer	9.82e-05	0.00158	CcSEcCtD
Simvastatin—ITGB2—Adaptive Immune System—MDM2—bone cancer	9.74e-05	0.000907	CbGpPWpGaD
Simvastatin—ABCC2—Transmembrane transport of small molecules—TUBB2A—bone cancer	9.67e-05	0.0009	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—NDUFA12—bone cancer	9.62e-05	0.000896	CbGpPWpGaD
Simvastatin—Hypersensitivity—Epirubicin—bone cancer	9.57e-05	0.00154	CcSEcCtD
Simvastatin—Urticaria—Doxorubicin—bone cancer	9.55e-05	0.00153	CcSEcCtD
Simvastatin—Abdominal pain—Doxorubicin—bone cancer	9.5e-05	0.00153	CcSEcCtD
Simvastatin—Body temperature increased—Doxorubicin—bone cancer	9.5e-05	0.00153	CcSEcCtD
Simvastatin—Diarrhoea—Methotrexate—bone cancer	9.49e-05	0.00153	CcSEcCtD
Simvastatin—CYP2C8—Arachidonic acid metabolism—PTGS2—bone cancer	9.39e-05	0.000874	CbGpPWpGaD
Simvastatin—Asthenia—Epirubicin—bone cancer	9.32e-05	0.0015	CcSEcCtD
Simvastatin—CYP2B6—Biological oxidations—CYP3A4—bone cancer	9.32e-05	0.000867	CbGpPWpGaD
Simvastatin—HMGCR—Integrated Breast Cancer Pathway—EGFR—bone cancer	9.27e-05	0.000863	CbGpPWpGaD
Simvastatin—Pruritus—Epirubicin—bone cancer	9.19e-05	0.00148	CcSEcCtD
Simvastatin—CYP2B6—Metapathway biotransformation—CYP3A4—bone cancer	9.19e-05	0.000855	CbGpPWpGaD
Simvastatin—Dizziness—Methotrexate—bone cancer	9.18e-05	0.00147	CcSEcCtD
Simvastatin—UGT2B7—Metabolism—NT5C3A—bone cancer	9.15e-05	0.000852	CbGpPWpGaD
Simvastatin—CYP3A5—Biological oxidations—CYP3A4—bone cancer	9.1e-05	0.000848	CbGpPWpGaD
Simvastatin—SLCO1B1—Transmembrane transport of small molecules—TUBB2A—bone cancer	9.08e-05	0.000846	CbGpPWpGaD
Simvastatin—CYP3A5—Metapathway biotransformation—CYP3A4—bone cancer	8.98e-05	0.000836	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—NDUFA12—bone cancer	8.98e-05	0.000836	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	8.96e-05	0.000834	CbGpPWpGaD
Simvastatin—Diarrhoea—Epirubicin—bone cancer	8.88e-05	0.00143	CcSEcCtD
Simvastatin—Hypersensitivity—Doxorubicin—bone cancer	8.85e-05	0.00142	CcSEcCtD
Simvastatin—Vomiting—Methotrexate—bone cancer	8.82e-05	0.00142	CcSEcCtD
Simvastatin—ITGB2—Innate Immune System—JUN—bone cancer	8.81e-05	0.000821	CbGpPWpGaD
Simvastatin—Rash—Methotrexate—bone cancer	8.75e-05	0.00141	CcSEcCtD
Simvastatin—Dermatitis—Methotrexate—bone cancer	8.74e-05	0.0014	CcSEcCtD
Simvastatin—Headache—Methotrexate—bone cancer	8.69e-05	0.0014	CcSEcCtD
Simvastatin—Asthenia—Doxorubicin—bone cancer	8.62e-05	0.00139	CcSEcCtD
Simvastatin—Dizziness—Epirubicin—bone cancer	8.59e-05	0.00138	CcSEcCtD
Simvastatin—Pruritus—Doxorubicin—bone cancer	8.5e-05	0.00137	CcSEcCtD
Simvastatin—CYP2C19—Arachidonic acid metabolism—PTGS2—bone cancer	8.38e-05	0.00078	CbGpPWpGaD
Simvastatin—Vomiting—Epirubicin—bone cancer	8.26e-05	0.00133	CcSEcCtD
Simvastatin—Nausea—Methotrexate—bone cancer	8.24e-05	0.00132	CcSEcCtD
Simvastatin—SLCO1B1—Metabolism—NDUFA12—bone cancer	8.23e-05	0.000766	CbGpPWpGaD
Simvastatin—Diarrhoea—Doxorubicin—bone cancer	8.22e-05	0.00132	CcSEcCtD
Simvastatin—Rash—Epirubicin—bone cancer	8.19e-05	0.00132	CcSEcCtD
Simvastatin—Dermatitis—Epirubicin—bone cancer	8.18e-05	0.00131	CcSEcCtD
Simvastatin—Headache—Epirubicin—bone cancer	8.14e-05	0.00131	CcSEcCtD
Simvastatin—SLCO1A2—Metabolism—NT5C3A—bone cancer	7.97e-05	0.000742	CbGpPWpGaD
Simvastatin—CYP2B6—Biological oxidations—GSTP1—bone cancer	7.97e-05	0.000742	CbGpPWpGaD
Simvastatin—Dizziness—Doxorubicin—bone cancer	7.95e-05	0.00128	CcSEcCtD
Simvastatin—CYP2C8—Biological oxidations—CYP3A4—bone cancer	7.89e-05	0.000734	CbGpPWpGaD
Simvastatin—CYP2B6—Metapathway biotransformation—GSTP1—bone cancer	7.86e-05	0.000732	CbGpPWpGaD
Simvastatin—CYP3A5—Biological oxidations—GSTP1—bone cancer	7.79e-05	0.000725	CbGpPWpGaD
Simvastatin—HMGCR—Integrated Breast Cancer Pathway—TP53—bone cancer	7.78e-05	0.000724	CbGpPWpGaD
Simvastatin—CYP2C8—Metapathway biotransformation—CYP3A4—bone cancer	7.78e-05	0.000724	CbGpPWpGaD
Simvastatin—Nausea—Epirubicin—bone cancer	7.71e-05	0.00124	CcSEcCtD
Simvastatin—CYP3A5—Metapathway biotransformation—GSTP1—bone cancer	7.68e-05	0.000715	CbGpPWpGaD
Simvastatin—CYP2C9—Arachidonic acid metabolism—PTGS2—bone cancer	7.64e-05	0.000711	CbGpPWpGaD
Simvastatin—Vomiting—Doxorubicin—bone cancer	7.64e-05	0.00123	CcSEcCtD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	7.62e-05	0.000709	CbGpPWpGaD
Simvastatin—Rash—Doxorubicin—bone cancer	7.58e-05	0.00122	CcSEcCtD
Simvastatin—Dermatitis—Doxorubicin—bone cancer	7.57e-05	0.00122	CcSEcCtD
Simvastatin—CYP3A7—Metabolism—NDUFA12—bone cancer	7.55e-05	0.000703	CbGpPWpGaD
Simvastatin—Headache—Doxorubicin—bone cancer	7.53e-05	0.00121	CcSEcCtD
Simvastatin—ITGB2—Immune System—KIT—bone cancer	7.5e-05	0.000698	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—NT5C3A—bone cancer	7.44e-05	0.000693	CbGpPWpGaD
Simvastatin—Nausea—Doxorubicin—bone cancer	7.14e-05	0.00115	CcSEcCtD
Simvastatin—CYP2C19—Biological oxidations—CYP3A4—bone cancer	7.04e-05	0.000655	CbGpPWpGaD
Simvastatin—CYP2C19—Metapathway biotransformation—CYP3A4—bone cancer	6.94e-05	0.000646	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	6.94e-05	0.000646	CbGpPWpGaD
Simvastatin—ITGB2—Innate Immune System—EGFR—bone cancer	6.93e-05	0.000645	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—NT5C3A—bone cancer	6.82e-05	0.000635	CbGpPWpGaD
Simvastatin—CYP2C8—Biological oxidations—GSTP1—bone cancer	6.74e-05	0.000628	CbGpPWpGaD
Simvastatin—ITGB2—Adaptive Immune System—EGFR—bone cancer	6.65e-05	0.00062	CbGpPWpGaD
Simvastatin—CYP2C8—Metapathway biotransformation—GSTP1—bone cancer	6.65e-05	0.000619	CbGpPWpGaD
Simvastatin—CYP2D6—Biological oxidations—CYP3A4—bone cancer	6.47e-05	0.000603	CbGpPWpGaD
Simvastatin—ITGB2—Hemostasis—TP53—bone cancer	6.46e-05	0.000602	CbGpPWpGaD
Simvastatin—CYP2C9—Biological oxidations—CYP3A4—bone cancer	6.42e-05	0.000598	CbGpPWpGaD
Simvastatin—CYP2D6—Metapathway biotransformation—CYP3A4—bone cancer	6.39e-05	0.000594	CbGpPWpGaD
Simvastatin—CYP2C9—Metapathway biotransformation—CYP3A4—bone cancer	6.33e-05	0.000589	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	6.32e-05	0.000588	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—NT5C3A—bone cancer	6.26e-05	0.000582	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	6.23e-05	0.00058	CbGpPWpGaD
Simvastatin—CYP2C19—Biological oxidations—GSTP1—bone cancer	6.02e-05	0.00056	CbGpPWpGaD
Simvastatin—CYP2C19—Metapathway biotransformation—GSTP1—bone cancer	5.94e-05	0.000553	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—MDM2—bone cancer	5.91e-05	0.00055	CbGpPWpGaD
Simvastatin—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	5.91e-05	0.00055	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism—ENO2—bone cancer	5.78e-05	0.000539	CbGpPWpGaD
Simvastatin—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	5.59e-05	0.00052	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—NDUFA12—bone cancer	5.58e-05	0.00052	CbGpPWpGaD
Simvastatin—CYP2D6—Biological oxidations—GSTP1—bone cancer	5.54e-05	0.000516	CbGpPWpGaD
Simvastatin—CYP2C9—Biological oxidations—GSTP1—bone cancer	5.49e-05	0.000511	CbGpPWpGaD
Simvastatin—CYP2D6—Metapathway biotransformation—GSTP1—bone cancer	5.46e-05	0.000508	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—NDUFA12—bone cancer	5.46e-05	0.000508	CbGpPWpGaD
Simvastatin—CYP2C9—Metapathway biotransformation—GSTP1—bone cancer	5.41e-05	0.000504	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism—DHFR—bone cancer	5.37e-05	0.0005	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	5.28e-05	0.000492	CbGpPWpGaD
Simvastatin—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	5.27e-05	0.00049	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—JUN—bone cancer	5.13e-05	0.000478	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism—GNA11—bone cancer	5.02e-05	0.000467	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—NDUFA12—bone cancer	4.73e-05	0.00044	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—ENO2—bone cancer	4.72e-05	0.000439	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—NT5C3A—bone cancer	4.63e-05	0.000431	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism—CYP3A4—bone cancer	4.55e-05	0.000423	CbGpPWpGaD
Simvastatin—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	4.55e-05	0.000423	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	4.52e-05	0.000421	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—NT5C3A—bone cancer	4.52e-05	0.000421	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—DHFR—bone cancer	4.37e-05	0.000407	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—NDUFA12—bone cancer	4.22e-05	0.000393	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—NDUFA12—bone cancer	4.12e-05	0.000383	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—GNA11—bone cancer	4.09e-05	0.000381	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—EGFR—bone cancer	4.04e-05	0.000376	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—ENO2—bone cancer	4.01e-05	0.000373	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	3.92e-05	0.000365	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—NT5C3A—bone cancer	3.92e-05	0.000365	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism—GSTP1—bone cancer	3.89e-05	0.000362	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—NDUFA12—bone cancer	3.88e-05	0.000361	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—NDUFA12—bone cancer	3.85e-05	0.000358	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—DHFR—bone cancer	3.72e-05	0.000346	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—CYP3A4—bone cancer	3.71e-05	0.000345	CbGpPWpGaD
Simvastatin—CYP3A4—Biological oxidations—GSTP1—bone cancer	3.62e-05	0.000337	CbGpPWpGaD
Simvastatin—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	3.57e-05	0.000332	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—NT5C3A—bone cancer	3.5e-05	0.000325	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—ENO2—bone cancer	3.49e-05	0.000325	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—GNA11—bone cancer	3.48e-05	0.000324	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—NT5C3A—bone cancer	3.41e-05	0.000318	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—ENO2—bone cancer	3.26e-05	0.000303	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—DHFR—bone cancer	3.24e-05	0.000302	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—NT5C3A—bone cancer	3.22e-05	0.000299	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—NT5C3A—bone cancer	3.19e-05	0.000297	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—GSTP1—bone cancer	3.17e-05	0.000295	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—CYP3A4—bone cancer	3.15e-05	0.000293	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—GNA11—bone cancer	3.03e-05	0.000282	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—DHFR—bone cancer	3.02e-05	0.000281	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—ENO2—bone cancer	2.99e-05	0.000278	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	2.9e-05	0.00027	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—GNA11—bone cancer	2.83e-05	0.000263	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	2.8e-05	0.000261	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—DHFR—bone cancer	2.77e-05	0.000258	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—CYP3A4—bone cancer	2.74e-05	0.000256	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—ENO2—bone cancer	2.74e-05	0.000255	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.73e-05	0.000254	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—GSTP1—bone cancer	2.7e-05	0.000251	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—GNA11—bone cancer	2.59e-05	0.000241	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—CYP3A4—bone cancer	2.56e-05	0.000238	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—DHFR—bone cancer	2.54e-05	0.000237	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—NDUFA12—bone cancer	2.54e-05	0.000236	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	2.52e-05	0.000235	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—GNA11—bone cancer	2.38e-05	0.000221	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—GSTP1—bone cancer	2.35e-05	0.000219	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—CYP3A4—bone cancer	2.35e-05	0.000219	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.34e-05	0.000217	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—GSTP1—bone cancer	2.19e-05	0.000204	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—CYP3A4—bone cancer	2.15e-05	0.000201	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—NT5C3A—bone cancer	2.1e-05	0.000196	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—ENO2—bone cancer	2.03e-05	0.000189	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism—PTGS2—bone cancer	2.01e-05	0.000188	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—GSTP1—bone cancer	2.01e-05	0.000187	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	1.98e-05	0.000185	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—ENO2—bone cancer	1.98e-05	0.000184	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—DHFR—bone cancer	1.88e-05	0.000175	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—GSTP1—bone cancer	1.84e-05	0.000172	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—DHFR—bone cancer	1.84e-05	0.000171	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—GNA11—bone cancer	1.76e-05	0.000164	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—GNA11—bone cancer	1.72e-05	0.00016	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—ENO2—bone cancer	1.72e-05	0.00016	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	1.67e-05	0.000155	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—PTGS2—bone cancer	1.64e-05	0.000153	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—CYP3A4—bone cancer	1.59e-05	0.000148	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—DHFR—bone cancer	1.59e-05	0.000148	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—CYP3A4—bone cancer	1.56e-05	0.000145	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—ENO2—bone cancer	1.53e-05	0.000143	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—ENO2—bone cancer	1.49e-05	0.000139	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—GNA11—bone cancer	1.49e-05	0.000138	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—DHFR—bone cancer	1.42e-05	0.000132	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—ENO2—bone cancer	1.41e-05	0.000131	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—PTGS2—bone cancer	1.4e-05	0.00013	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—ENO2—bone cancer	1.4e-05	0.00013	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—DHFR—bone cancer	1.39e-05	0.000129	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—GSTP1—bone cancer	1.36e-05	0.000127	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—CYP3A4—bone cancer	1.35e-05	0.000126	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.34e-05	0.000125	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—GSTP1—bone cancer	1.33e-05	0.000124	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—GNA11—bone cancer	1.33e-05	0.000124	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—DHFR—bone cancer	1.31e-05	0.000122	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—GNA11—bone cancer	1.3e-05	0.000121	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—DHFR—bone cancer	1.3e-05	0.000121	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—GNA11—bone cancer	1.22e-05	0.000114	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—PTGS2—bone cancer	1.22e-05	0.000113	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—GNA11—bone cancer	1.21e-05	0.000113	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—CYP3A4—bone cancer	1.2e-05	0.000112	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.2e-05	0.000111	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—CYP3A4—bone cancer	1.17e-05	0.000109	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—GSTP1—bone cancer	1.15e-05	0.000107	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—PTGS2—bone cancer	1.13e-05	0.000106	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—CYP3A4—bone cancer	1.11e-05	0.000103	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—CYP3A4—bone cancer	1.1e-05	0.000102	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.09e-05	0.000102	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—PTGS2—bone cancer	1.04e-05	9.68e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—GSTP1—bone cancer	1.03e-05	9.58e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—GSTP1—bone cancer	1e-05	9.36e-05	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—PTGS2—bone cancer	9.54e-06	8.89e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—GSTP1—bone cancer	9.47e-06	8.82e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—GSTP1—bone cancer	9.39e-06	8.74e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—ENO2—bone cancer	9.21e-06	8.57e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—DHFR—bone cancer	8.54e-06	7.95e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—GNA11—bone cancer	7.98e-06	7.43e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—PTGS2—bone cancer	7.06e-06	6.57e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—PTGS2—bone cancer	6.9e-06	6.42e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—GSTP1—bone cancer	6.19e-06	5.76e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—PTGS2—bone cancer	5.98e-06	5.56e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—PTGS2—bone cancer	5.33e-06	4.97e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—PTGS2—bone cancer	5.21e-06	4.85e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—PTGS2—bone cancer	4.91e-06	4.57e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—PTGS2—bone cancer	4.86e-06	4.53e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—PTGS2—bone cancer	3.21e-06	2.99e-05	CbGpPWpGaD
